• PDF / 167,222 Bytes
• 1 Pages / 595.245 x 841.846 pts (A4) Page_size
• 46 Downloads / 231 Views

DOWNLOAD

REPORT

1173-5503/20/0861-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved

PharmacoEconomics & Outcomes News 5 Sep 2020 No. 861

1

Recommend Documents

NICE recommends apixiban and ranibizumab . . .

165 13 112KB

NICE recommends caplacizumab for acute acquired TTP

149 71 163KB

NICE recommends isatuximab with pomalidomide and dexamethasone

151 71 163KB

NICE recommends osimertinib for advanced EGFR-positive NSCLC

159 54 163KB

NICE recommends Zio XT for detecting arrhythmias, with a caveat

182 15 163KB

Adding polatuzumab vedotin cost effective in large B-cell lymphoma

152 35 163KB

NICE recommends BP monitor for atrial fibrillation detection

151 70 83KB

NICE recommends liraglutide & venetoclax + obinutuzumab, but not nivolumab

148 79 168KB

Brentuximab vedotin

131 96 166KB

Brentuximab vedotin

136 95 165KB

Nice Numbers

192 57 12MB

Brentuximab vedotin

122 79 155KB